開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
ArcelorMittal SA said its plants were operating normally during the attack.
2026-08-17
ArcelorMittal SA said its plants were operating normally during the attack.
返回
其他消息
2026-08-17
Aug 17 — AstraZeneca said Tezspire (tezepelumab) is now commercially available in China. In March 2026 tezepelumab was approved in China, based on positive Phase III DIRECTION and WAYPOINT trials, for two indications: maintenance treatment of severe asthma in adults and adolescents aged 12 and over; and, as an add-on to intranasal corticosteroids, treatment of adult chronic rhinosinusitis with nasal polyps (CRSwNP) not adequately controlled by systemic corticosteroids and/or surgery.
Aug 17 — AstraZeneca said Tezspire (tezepelumab) is now commercially available in China. In March 2026 tezepelumab was approved in China, based on positive Phase III DIRECTION and WAYPOINT trials, for two indications: maintenance treatment of severe asthma in adults and adolescents aged 12 and over; and, as an add-on to intranasal corticosteroids, treatment of adult chronic rhinosinusitis with nasal polyps (CRSwNP) not adequately controlled by systemic corticosteroids and/or surgery.
2026-08-17
午盤收盤,國內期貨主力合約漲多跌少,集運歐線漲超10%,乙二醇(EG)漲超6%,PTA漲超5%,合成橡膠、純苯漲超4%,對二甲苯、SC原油、苯乙烯(EB)漲超3%。跌幅方面,玉米、澱粉跌超1%。
午盤收盤,國內期貨主力合約漲多跌少,集運歐線漲超10%,乙二醇(EG)漲超6%,PTA漲超5%,合成橡膠、純苯漲超4%,對二甲苯、SC原油、苯乙烯(EB)漲超3%。跌幅方面,玉米、澱粉跌超1%。
Chat with us
, powered by
LiveChat